Suicidal crisis and suicide prevention : psychopharmacological aspects

Suicide is a common cause of death in Switzerland. It often occurs during a period of crisis marked by a disruption of the subject's intrapsychic, interpersonal or social balance. The management of this crisis is crucial and essentially psychotherapeutic. Drug therapy may be necessary for the m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revue médicale suisse 2020-02, Vol.16 (681), p.314
Hauptverfasser:	de Néris, Mélanie, Costanza, Alessandra, Besson, Marie, Greiner, Christian, Prada, Paco, Ambrosetti, Julia
Format:	Artikel
Sprache:	fre
Schlagworte:	Antipsychotic Agents - pharmacology Benzodiazepines - pharmacology Borderline Personality Disorder - psychology Humans Risk Factors Suicidal Ideation Suicide - prevention & control Suicide - psychology Switzerland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	681
container_start_page	314
container_title	Revue médicale suisse
container_volume	16
creator	de Néris, Mélanie Costanza, Alessandra Besson, Marie Greiner, Christian Prada, Paco Ambrosetti, Julia
description	Suicide is a common cause of death in Switzerland. It often occurs during a period of crisis marked by a disruption of the subject's intrapsychic, interpersonal or social balance. The management of this crisis is crucial and essentially psychotherapeutic. Drug therapy may be necessary for the management of acute symptoms or for the prevention of long-term suicidal risk. Benzodiazepines and atypical antipsychotics are often used for acute symptoms such as anxiety or sleep disorders while other molecules are recognized in reducing long-term suicidal risk. Some disorders, such as borderline personality disorder, account for more frequent suicidal behaviors. The pharmacological management of these specific situations is discussed.
format	Article
fullrecord	<record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_32049453</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32049453</sourcerecordid><originalsourceid>FETCH-pubmed_primary_320494533</originalsourceid><addsrcrecordid>eNpjYeA0NDMz0LU0NrfkYOAtLs4yAAIzQ2MjI2N2Bg5jIwMTSxNTY04Gj-DSzOTMlMQcheSizOLMYoXEvBSFYrBYqkJBUWpZal5JZn7eo4ZWK4WC4srkjPyCjMSi3MTk_Jz89MxkoL7E4oLU5JJiHgbWtMSc4lReKM3NIOfmGuLsoVtQmpSbmhJfUJSZm1hUGQ-z2pigAgDqZzu_</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Suicidal crisis and suicide prevention : psychopharmacological aspects</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>de Néris, Mélanie ; Costanza, Alessandra ; Besson, Marie ; Greiner, Christian ; Prada, Paco ; Ambrosetti, Julia</creator><creatorcontrib>de Néris, Mélanie ; Costanza, Alessandra ; Besson, Marie ; Greiner, Christian ; Prada, Paco ; Ambrosetti, Julia</creatorcontrib><description>Suicide is a common cause of death in Switzerland. It often occurs during a period of crisis marked by a disruption of the subject's intrapsychic, interpersonal or social balance. The management of this crisis is crucial and essentially psychotherapeutic. Drug therapy may be necessary for the management of acute symptoms or for the prevention of long-term suicidal risk. Benzodiazepines and atypical antipsychotics are often used for acute symptoms such as anxiety or sleep disorders while other molecules are recognized in reducing long-term suicidal risk. Some disorders, such as borderline personality disorder, account for more frequent suicidal behaviors. The pharmacological management of these specific situations is discussed.</description><identifier>ISSN: 1660-9379</identifier><identifier>PMID: 32049453</identifier><language>fre</language><publisher>Switzerland</publisher><subject>Antipsychotic Agents - pharmacology ; Benzodiazepines - pharmacology ; Borderline Personality Disorder - psychology ; Humans ; Risk Factors ; Suicidal Ideation ; Suicide - prevention & control ; Suicide - psychology ; Switzerland</subject><ispartof>Revue médicale suisse, 2020-02, Vol.16 (681), p.314</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32049453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Néris, Mélanie</creatorcontrib><creatorcontrib>Costanza, Alessandra</creatorcontrib><creatorcontrib>Besson, Marie</creatorcontrib><creatorcontrib>Greiner, Christian</creatorcontrib><creatorcontrib>Prada, Paco</creatorcontrib><creatorcontrib>Ambrosetti, Julia</creatorcontrib><title>Suicidal crisis and suicide prevention : psychopharmacological aspects</title><title>Revue médicale suisse</title><addtitle>Rev Med Suisse</addtitle><description>Suicide is a common cause of death in Switzerland. It often occurs during a period of crisis marked by a disruption of the subject's intrapsychic, interpersonal or social balance. The management of this crisis is crucial and essentially psychotherapeutic. Drug therapy may be necessary for the management of acute symptoms or for the prevention of long-term suicidal risk. Benzodiazepines and atypical antipsychotics are often used for acute symptoms such as anxiety or sleep disorders while other molecules are recognized in reducing long-term suicidal risk. Some disorders, such as borderline personality disorder, account for more frequent suicidal behaviors. The pharmacological management of these specific situations is discussed.</description><subject>Antipsychotic Agents - pharmacology</subject><subject>Benzodiazepines - pharmacology</subject><subject>Borderline Personality Disorder - psychology</subject><subject>Humans</subject><subject>Risk Factors</subject><subject>Suicidal Ideation</subject><subject>Suicide - prevention & control</subject><subject>Suicide - psychology</subject><subject>Switzerland</subject><issn>1660-9379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpjYeA0NDMz0LU0NrfkYOAtLs4yAAIzQ2MjI2N2Bg5jIwMTSxNTY04Gj-DSzOTMlMQcheSizOLMYoXEvBSFYrBYqkJBUWpZal5JZn7eo4ZWK4WC4srkjPyCjMSi3MTk_Jz89MxkoL7E4oLU5JJiHgbWtMSc4lReKM3NIOfmGuLsoVtQmpSbmhJfUJSZm1hUGQ-z2pigAgDqZzu_</recordid><startdate>20200212</startdate><enddate>20200212</enddate><creator>de Néris, Mélanie</creator><creator>Costanza, Alessandra</creator><creator>Besson, Marie</creator><creator>Greiner, Christian</creator><creator>Prada, Paco</creator><creator>Ambrosetti, Julia</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20200212</creationdate><title>Suicidal crisis and suicide prevention : psychopharmacological aspects</title><author>de Néris, Mélanie ; Costanza, Alessandra ; Besson, Marie ; Greiner, Christian ; Prada, Paco ; Ambrosetti, Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_320494533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2020</creationdate><topic>Antipsychotic Agents - pharmacology</topic><topic>Benzodiazepines - pharmacology</topic><topic>Borderline Personality Disorder - psychology</topic><topic>Humans</topic><topic>Risk Factors</topic><topic>Suicidal Ideation</topic><topic>Suicide - prevention & control</topic><topic>Suicide - psychology</topic><topic>Switzerland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Néris, Mélanie</creatorcontrib><creatorcontrib>Costanza, Alessandra</creatorcontrib><creatorcontrib>Besson, Marie</creatorcontrib><creatorcontrib>Greiner, Christian</creatorcontrib><creatorcontrib>Prada, Paco</creatorcontrib><creatorcontrib>Ambrosetti, Julia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Revue médicale suisse</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Néris, Mélanie</au><au>Costanza, Alessandra</au><au>Besson, Marie</au><au>Greiner, Christian</au><au>Prada, Paco</au><au>Ambrosetti, Julia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suicidal crisis and suicide prevention : psychopharmacological aspects</atitle><jtitle>Revue médicale suisse</jtitle><addtitle>Rev Med Suisse</addtitle><date>2020-02-12</date><risdate>2020</risdate><volume>16</volume><issue>681</issue><spage>314</spage><pages>314-</pages><issn>1660-9379</issn><abstract>Suicide is a common cause of death in Switzerland. It often occurs during a period of crisis marked by a disruption of the subject's intrapsychic, interpersonal or social balance. The management of this crisis is crucial and essentially psychotherapeutic. Drug therapy may be necessary for the management of acute symptoms or for the prevention of long-term suicidal risk. Benzodiazepines and atypical antipsychotics are often used for acute symptoms such as anxiety or sleep disorders while other molecules are recognized in reducing long-term suicidal risk. Some disorders, such as borderline personality disorder, account for more frequent suicidal behaviors. The pharmacological management of these specific situations is discussed.</abstract><cop>Switzerland</cop><pmid>32049453</pmid></addata></record>
fulltext	fulltext
identifier	ISSN: 1660-9379
ispartof	Revue médicale suisse, 2020-02, Vol.16 (681), p.314
issn	1660-9379
language	fre
recordid	cdi_pubmed_primary_32049453
source	MEDLINE; Alma/SFX Local Collection
subjects	Antipsychotic Agents - pharmacology Benzodiazepines - pharmacology Borderline Personality Disorder - psychology Humans Risk Factors Suicidal Ideation Suicide - prevention & control Suicide - psychology Switzerland
title	Suicidal crisis and suicide prevention : psychopharmacological aspects
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A51%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suicidal%20crisis%20and%20suicide%20prevention%E2%80%85:%20psychopharmacological%20aspects&rft.jtitle=Revue%20m%C3%A9dicale%20suisse&rft.au=de%20N%C3%A9ris,%20M%C3%A9lanie&rft.date=2020-02-12&rft.volume=16&rft.issue=681&rft.spage=314&rft.pages=314-&rft.issn=1660-9379&rft_id=info:doi/&rft_dat=%3Cpubmed%3E32049453%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32049453&rfr_iscdi=true